Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDP antisense RNA 1 (NDP-AS1) is a long noncoding antisense RNA transcribed from the NDP locus on the human genome[3]. This molecule does not encode a protein but may regulate expression of its sense gene through various epigenetic and transcriptional mechanisms common to antisense RNAs. Such RNAs typically act by modulating transcription rates, influencing the methylation or chromatin status of the associated sense gene region, or through RNA-RNA interaction affecting mRNA stability and translation efficiency[1][2][3]. While antisense lncRNAs are often involved in diseases by silencing tumor suppressor genes or modulating disease pathways, there is no published evidence (as of September 2025) that NDP-AS1 itself has a definitive disease role or is a target for drugs. The gene is annotated in genetic databases, but further research is needed to clarify its specific biological and clinical significance[3].
No drugs target NDP-AS1, but generally, antisense RNAs may be modulated by antisense oligonucleotides (ASOs) to downregulate or alter gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NDP antisense RNA 1 (non-protein coding) (NDP-AS1).